Published in Contact Dermatitis on June 01, 2008
Absorption of chemicals through compromised skin. Int Arch Occup Environ Health (2009) 0.77
Kinetics of Clobetasol-17-Propionate in Psoriatic Lesional and Non-Lesional Skin Assessed by Dermal Open Flow Microperfusion with Time and Space Resolution. Pharm Res (2016) 0.77
Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. Pharm Res (2007) 7.87
Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm (2004) 2.63
FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms. AAPS PharmSciTech (2003) 2.03
Severe allergic hair dye reactions in 8 children. Contact Dermatitis (2006) 1.82
Biopharmaceutics classification system: the scientific basis for biowaiver extensions. Pharm Res (2002) 1.74
Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol (2003) 1.61
Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis. Nat Genet (2011) 1.60
Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim Biophys Acta (2008) 1.58
The use of BDDCS in classifying the permeability of marketed drugs. Pharm Res (2008) 1.57
Metal allergen of the 21st century--a review on exposure, epidemiology and clinical manifestations of palladium allergy. Contact Dermatitis (2011) 1.54
The epidemiology of contact allergy in the general population--prevalence and main findings. Contact Dermatitis (2007) 1.51
Heritability of hand eczema is not explained by comorbidity with atopic dermatitis. J Invest Dermatol (2007) 1.49
The epidemiology of hand eczema in the general population--prevalence and main findings. Contact Dermatitis (2010) 1.43
Mercaptobenzothiazole or the mercapto-mix: which should be in the standard series? Contact Dermatitis (2006) 1.39
Genetic factors in nickel allergy evaluated in a population-based female twin sample. J Invest Dermatol (2004) 1.38
Standardization in Contact Dermatitis. Contact Dermatitis (2008) 1.38
AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives. Pharm Res (2007) 1.35
Metal allergy--a review on exposures, penetration, genetics, prevalence, and clinical implications. Chem Res Toxicol (2010) 1.31
The association between metal allergy, total hip arthroplasty, and revision. Acta Orthop (2009) 1.26
Nickel, chromium and cobalt in consumer products: revisiting safe levels in the new millennium. Contact Dermatitis (2003) 1.14
Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the Americas. AAPS J (2012) 1.12
Coin exposure may cause allergic nickel dermatitis: a review. Contact Dermatitis (2012) 1.11
Breastfeeding and risk of atopic dermatitis, by parental history of allergy, during the first 18 months of life. Am J Epidemiol (2004) 1.09
Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatr (2004) 1.04
Summary workshop report: bioequivalence, biopharmaceutics classification system, and beyond. AAPS J (2008) 1.01
One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol (2008) 1.01
AAPS-FDA Workshop White Paper: microdialysis principles, application, and regulatory perspectives. J Clin Pharmacol (2007) 1.01
Hypersensitivity reactions to metallic implants - diagnostic algorithm and suggested patch test series for clinical use. Contact Dermatitis (2011) 1.01
Skin barrier abnormality caused by filaggrin (FLG) mutations is associated with increased serum 25-hydroxyvitamin D concentrations. J Allergy Clin Immunol (2012) 1.00
Nickel allergy in Danish women before and after nickel regulation. N Engl J Med (2009) 0.99
Dietary fat decreases intestinal levels of the anorectic lipids through a fat sensor. FASEB J (2010) 0.99
Assessment of dermatopharmacokinetic approach in the bioequivalence determination of topical tretinoin gel products. J Am Acad Dermatol (2003) 0.98
A prospective study of patient adherence to topical treatments: 95% of patients underdose. J Am Acad Dermatol (2008) 0.97
Experimental systemic contact dermatitis from nickel: a dose-response study. Contact Dermatitis (2003) 0.96
Conference report: Bio-International 2005. J Pharm Sci (2007) 0.95
Vitamin D status, filaggrin genotype, and cardiovascular risk factors: a Mendelian randomization approach. PLoS One (2013) 0.95
Quantitative aspects of contact allergy to chromium and exposure to chrome-tanned leather. Contact Dermatitis (2002) 0.95
Hypersensitivity to local anaesthetics--update and proposal of evaluation algorithm. Contact Dermatitis (2008) 0.92
Characterization of lymphocyte subpopulations and cytokine profiles in peripheral blood of nickel-sensitive individuals with systemic contact dermatitis after oral nickel exposure. Contact Dermatitis (2004) 0.92
Association between cancer and contact allergy: a linkage study. BMJ Open (2011) 0.92
Interaction between filaggrin null mutations and tobacco smoking in relation to asthma. J Allergy Clin Immunol (2011) 0.91
Qualification of analytical instruments for use in the pharmaceutical industry: a scientific approach. AAPS PharmSciTech (2004) 0.91
Biowaiver monographs for immediate release solid oral dosage forms: metronidazole. J Pharm Sci (2011) 0.89
Investigation of racemisation of the enantiomers of glitazone drug compounds at different pH using chiral HPLC and chiral CE. J Pharm Biomed Anal (2007) 0.88
Chromium in leather footwear - risk assessment of chromium allergy and dermatitis. Contact Dermatitis (2012) 0.88
Spectrophotometric determination of propranolol in formulations via oxidative coupling with 3-methylbenzothiazoline-2-one hydrazone. Farmaco (2003) 0.88
Smoking might be a risk factor for contact allergy. J Allergy Clin Immunol (2003) 0.87
Patch test reactivity to metal allergens following regulatory interventions: a 33-year retrospective study. Contact Dermatitis (2010) 0.87
HuMax-CD4: a fully human monoclonal anti-CD4 antibody for the treatment of psoriasis vulgaris. Arch Dermatol (2003) 0.87
Formaldehyde exposure and patterns of concomitant contact allergy to formaldehyde and formaldehyde-releasers. Contact Dermatitis (2010) 0.87
Sensitivity and specificity of the nickel spot (dimethylglyoxime) test. Contact Dermatitis (2010) 0.87
Contact allergy to epoxy resin: risk occupations and consequences. Contact Dermatitis (2012) 0.87
Validation of USP apparatus 4 method for microsphere in vitro release testing using Risperdal Consta. Int J Pharm (2011) 0.86
Hair dye contact allergy: quantitative exposure assessment of selected products and clinical cases. Contact Dermatitis (2004) 0.86
Challenges and opportunities in establishing scientific and regulatory standards for assuring therapeutic equivalence of modified-release products: workshop summary report. Eur J Pharm Sci (2010) 0.86
Filaggrin null mutations and association with contact allergy and allergic contact dermatitis: results from a tertiary dermatology clinic. Contact Dermatitis (2010) 0.86
A novel multiplex analysis of filaggrin polymorphisms: a universally applicable method for genotyping. Clin Chim Acta (2012) 0.86
A possible association between a dysfunctional skin barrier (filaggrin null-mutation status) and diabetes: a cross-sectional study. BMJ Open (2011) 0.86
Inflammatory bowel disease in relation to contact allergy: a patient-based study. Scand J Gastroenterol (2007) 0.86
Harmonization of regulatory approaches for evaluating therapeutic equivalence and interchangeability of multisource drug products: workshop summary report. Eur J Pharm Sci (2011) 0.86
Atopic dermatitis in young children: diagnostic criteria for use in epidemiological studies based on telephone interviews. Acta Derm Venereol (2003) 0.85
The association between metal allergy, total knee arthroplasty, and revision: study based on the Danish Knee Arthroplasty Register. Acta Orthop (2015) 0.85
Metabolic activation of carboxylic acids. Expert Opin Drug Metab Toxicol (2008) 0.85
Models for predicting blood-brain barrier permeation. Drug Discov Today (2011) 0.85
Bioequivalence of topical formulations in humans: evaluation by dermal microdialysis sampling and the dermatopharmacokinetic method. J Invest Dermatol (2006) 0.85
Visualization by mass spectrometry of 2-dimensional changes in rat brain lipids, including N-acylphosphatidylethanolamines, during neonatal brain ischemia. FASEB J (2012) 0.85
A standardized mini paddle apparatus as an alternative to the standard paddle. AAPS PharmSciTech (2008) 0.85
Contact allergy epidemics and their controls. Contact Dermatitis (2007) 0.84
Harmonization of regulatory approaches for evaluating therapeutic equivalence and interchangeability of multisource drug products: workshop summary report. AAPS J (2011) 0.84
Nickel reactivity and filaggrin null mutations--evaluation of the filaggrin bypass theory in a general population. Contact Dermatitis (2011) 0.84
A new sheathless electrospray interface for coupling of capillary electrophoresis to ion-trap mass spectrometry. Rapid Commun Mass Spectrom (2002) 0.84
Gene expression time course in the human skin during elicitation of allergic contact dermatitis. J Invest Dermatol (2007) 0.84
The outcome of dimethylglyoxime testing in a sample of cell phones in Denmark. Contact Dermatitis (2008) 0.84
Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain model. J Clin Pharmacol (2008) 0.84
Current challenges in bioequivalence, quality, and novel assessment technologies for topical products. Pharm Res (2014) 0.83
Occupational contact dermatitis in painters: an analysis of patch test data from the Danish Contact Dermatitis Group. Contact Dermatitis (2012) 0.83
Contact dermatitis caused by nickel release from hair clasps purchased in a country covered by the EU Nickel Directive. Contact Dermatitis (2009) 0.83
Formaldehyde-releasers: relationship to formaldehyde contact allergy. Contact allergy to formaldehyde and inventory of formaldehyde-releasers. Contact Dermatitis (2009) 0.83
Differentiated in vivo skin penetration of salicylic compounds in hairless rats measured by cutaneous microdialysis. Eur J Pharm Sci (2004) 0.83
Classification of atopic hand eczema and the filaggrin mutations. Contact Dermatitis (2008) 0.83
Application of dermal microdialysis for the evaluation of bioequivalence of a ketoprofen topical gel. Eur J Pharm Sci (2008) 0.83
Associations of filaggrin gene loss-of-function variants with urinary phthalate metabolites and testicular function in young Danish Men. Environ Health Perspect (2014) 0.83
Self-testing for contact sensitization to hair dyes--scientific considerations and clinical concerns of an industry-led screening programme. Contact Dermatitis (2012) 0.83
Clinical characteristics and consequences of hand eczema - an 8-year follow-up study of a population-based twin cohort. Contact Dermatitis (2008) 0.83
Biowaiver monographs for immediate-release solid oral dosage forms: primaquine phosphate. J Pharm Sci (2011) 0.83
Comparison of skin stripping, in vitro release, and skin blanching response methods to measure dose response and similarity of triamcinolone acetonide cream strengths from two manufactured sources. J Pharm Sci (2002) 0.82
Prevalence of nickel and cobalt allergy among female patients with dermatitis before and after Danish government regulation: a 23-year retrospective study. J Am Acad Dermatol (2009) 0.82
Pitfalls in the sample preparation and analysis of N-acylethanolamines. J Lipid Res (2010) 0.82
Hyphenation of solid-phase extraction with liquid chromatography and nuclear magnetic resonance: application of HPLC-DAD-SPE-NMR to identification of constituents of Kanahia laniflora. Anal Chem (2005) 0.82
Release of nickel ions from stainless steel alloys used in dental braces and their patch test reactivity in nickel-sensitive individuals. Contact Dermatitis (2003) 0.82
The EU Nickel Directive revisited--future steps towards better protection against nickel allergy. Contact Dermatitis (2011) 0.82
Cobalt allergy and suspected aseptic lymphocyte-dominated vascular-associated lesion following total hip arthroplasty. Contact Dermatitis (2009) 0.82
Assessment of nickel and cobalt release from 200 unused hand-held work tools for sale in Denmark - Sources of occupational metal contact dermatitis? Sci Total Environ (2011) 0.82
Clinical presentation of atopic dermatitis by filaggrin gene mutation status during the first 7 years of life in a prospective cohort study. PLoS One (2012) 0.81
Identification of metallic items that caused nickel dermatitis in Danish patients. Contact Dermatitis (2010) 0.81